T-cell allorecognition of donor glutathione S-transferase T1 in plasma cell-rich rejection

Table 1 Patient characteristics

Group	Patient	Gender	LT date	Original disease	Baseline IS	PBMC extraction date	Years after Tx	Treatment at PBMC extraction
1	1	M	06-05-99	Alcoholic cirrhosis	CYA (N), MMF, ST	12-04-12	13	CYA (N), MMF, ST
	2	F	07-05-07	Cirrhosis probably autoimmune	CYA, MMF, ST	16-04-12	5	CYA (N), MMF, ST
	3	F	02-07-00	HCV cirrhosis	CYA (N), ST, BASILISIMAB	13-03-12	12	TAC, AZA, ST
	4	F	18-09-03	Alcoholic cirrhosis	CYA, MMF, ST	09-05-12	9	TAC, MMF, ST
	5	M	02-11-01	HCV + alcoholic cirrhosis	CYA (N), ST, BASILISIMAB	14-06-12	11	MMF, ST
	6	F	27-03-09	Primary biliary cirrhosis	CYA, MMF	12-04-12	3	MMF, ST
	7	F	18-11-06	Secondary biliary cirrhosis	CYA (N), MMF, ST	08-05-12	6	CYA, MMF
2	8	M	23-11-96	HBV cirrhosis	CYA (N), MMF, ST	19-06-12	16	CYA (N), MMF
	9	F	03-06-96	Agenesis of the bile ducts	CYA, ST	21-05-12	16	TAC
3	10	M	12-7-06	Alcoholic cirrhosis + hepatocarcinoma	TAC, MMF, ST	16-04-12	6	MMF, SIR
	11	M	12-02-09	HBV cirrhosis	TAC, MMF, ST	16-04-12	3	MMF, SIR
	12	M	06-07-10	Non-alcoholic steatohepatitis	TAC (10 d) CYA, RAPA	17-04-12	2	MMF, SIR
	13	M	19-04-11	HCV cirrhosis+ hepatocarcinoma	CYA, ST	18-04-12	1	CYA, ST
	14	M	18-01-09	HCV cirrhosis	TAC, MMF, ST	02-05-12	3	TAC
	15	F	18-06-04	Alcoholic cirrhosis	TAC	07-05-12	8	MMF, EVE
	16	M	30-07-08	HCV cirrhosis	TAC, MMF, ST	08-05-12	4	MMF, EVE
	17	M	20-12-04	HCV cirrhosis	TAC, MMF, ST	22-05-12	7	TAC, MMF
	18	F	20-09-99	HCV cirrhosis	CYA, ST	18-06-12	13	CYA
4	E	F	09-03-09	Alcoholic cirrhosis	CYA, ST	21-03-12	3	CYA, MMF
	G	M	16-11-08	HCV cirrhosis	TAC, DACLIZUMAB	30-04-12	3	CYA
	J	F	22-05-10	Hepatocarcinoma	CYA, ST	02-05-12	2	CYA
	L	M	28-07-11	Primary biliary cirrhosis	TAC, MMF, ST	19-06-12	1	TAC

HBV: Hepatitis C virus; HCV: Hepatitis C virus.